Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: Results from the phase III, placebo-controlled QUAZAR AML-001 trial

1. Roboz, G.J.
2. Döhner, H.
3. Pocock, C.
4. Dombret, H.
5. Ravandi, F.
6. Jang, J.H.
7. Selleslag, D.
8. Mayer, J.
9. Martens, U.M.
10. Liesveld, J.
11. Bernal, T.
12. Wang, M.C.
13. Yu, P.
14. Shi, L.
15. Guo, S.
16. Torre, I.L.
17. Skikne, B.
18. Dong, Q.
19. Braverman, J.
20. Nehme, S.A.
21. Beach, C.L.
22. Wei, A.H.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3324/HAEMATOL.2021.279174 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus